Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Radiation therapy can help spare vision in patients with melanoma of the eye

19.10.2005


Treating a rare form of eye cancer with radiation therapy can spare patients from significant vision loss, according to new research at Wake Forest University Baptist Medical Center.



The research involved 57 patients with malignant melanoma of the uvea which is the pigmented layer of the eye. The results were reported today at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in Denver.

"These are very encouraging results," said Kathryn Greven, M.D., professor of radiation oncology and a study investigator. "The findings in this small series of patients with melanoma treated by Iodine 125 radioactive plaque confirm data obtained in a much larger, earlier study (COMS) that this procedure is effective in controlling the primary tumor, often with good visual outcomes."


Previously, the standard treatment for uveal melanoma was removal of the eye. But, the Collaborative Ocular Melanoma Study (COMS), a multicenter national trial reported in 2001 that radiation was a safe and effective alternative to removing the eye.

The current study involved plaque radiotherapy, which is the most frequently used system for delivering radiation to the eye tumor. With this treatment, a small metal shield containing radioactive seeds is sutured to the outside of the eye over the tumor. The shield is left in place until the required dose of radiation has been delivered, usually for four to five days. Several different type of radiation can be used in the seeds; this study used iodine 125.

The study found that at five years after radiation treatment, 90 percent of patients had their tumors controlled. Before treatment, patients’ median visual acuity was visual acuity was 20/30 (which means they could see from 20 feet away what someone with perfect vision can see from 30 feet away). After treatment, media visual acuity was 20/60. In almost half of patients (47 percent) vision was stable after treatment. The researchers found that patients with good pretreatment vision and thinner tumors had better visual outcomes. "Our results show that radiation is an excellent option for certain patients with malignant melanoma of the eye," said Greven.

Uveal malignant melanoma is a rare tumor that occurs in only six per one million people per year in the United States. It is more common in lightly pigmented people and is rarely seen in nonwhite races.

Kathryn Greven in the radiation oncology department and Craig Greven, M.D. a vitreoretinal surgeon in the ophthalmology department have been performing this procedure at Wake Forest University Baptist Medical Center since 1989.

Jonnie Rohrer | EurekAlert!
Further information:
http://www.wfubmc.edu

More articles from Health and Medicine:

nachricht Correct connections are crucial
26.06.2017 | Charité - Universitätsmedizin Berlin

nachricht One gene closer to regenerative therapy for muscular disorders
01.06.2017 | Cincinnati Children's Hospital Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Can we see monkeys from space? Emerging technologies to map biodiversity

An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.

Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...

Im Focus: Climate satellite: Tracking methane with robust laser technology

Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.

Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...

Im Focus: How protons move through a fuel cell

Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.

As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...

Im Focus: A unique data centre for cosmological simulations

Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.

With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...

Im Focus: Scientists develop molecular thermometer for contactless measurement using infrared light

Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine

Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Plants are networkers

19.06.2017 | Event News

Digital Survival Training for Executives

13.06.2017 | Event News

Global Learning Council Summit 2017

13.06.2017 | Event News

 
Latest News

Touch Displays WAY-AX and WAY-DX by WayCon

27.06.2017 | Power and Electrical Engineering

Drones that drive

27.06.2017 | Information Technology

Ultra-compact phase modulators based on graphene plasmons

27.06.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>